What does the research say about cardiomyopathy diagnosis?

Cardiomyopathy diagnosis

There is 1 paper on cardiomyopathy diagnosis in aging research: 1 observational study in people. The newest story, Nov 9, 2026: “About 1 in 347 in US carry heart disease-linked gene variants”.

Disease

1 paper studies it2 more mention it1 finding

2 new papers in 30 daysSee all 3 papers on cardiomyopathy diagnosis

“14.9% of TTN truncating carriers had a diagnosis of cardiomyopathy”

Real World Estimation of the Genetic and Clinical Prevalence of TTN-DCMAHA Scientific Sessions 2026 abstract2026doi:10.1161/circ.154.suppl_1.6787

Humans1

Associations

TTN

upin humans1

1 study

TTN is associated with cardiomyopathy diagnosis in humans (14.9% of truncating carriers versus 4.4% of splice site carriers and 2.8% of non-carriers).
“14.9% of TTN truncating carriers had a diagnosis of cardiomyopathy”
HumansTTN truncating variant carriers, splice site carriers, and non-carriers in the NIH All of Us cohort
About 1 in 347 in US carry heart disease-linked gene variants
AHA Scientific Sessions 2026 abstractNov 2, 2026

Latest

3 papers in 12 months

AHA Scientific Sessions 2026 AbstractNov 9

About 1 in 347 in US carry heart disease-linked gene variants

An observational analysis estimated 990,722 US carriers of disease-linked variants in the gene for titin, a muscle protein, using population genetic data.An observational analysis estimated 990,722 US carriers of disease-linked variants in the gene for titin, a muscle protein, using population genetic data.

Cross-sectional studyPopulations

Paper

ESC Congress 2026 AbstractOct 26

Lifetime risk of heart muscle disease was 2.5% in Sweden

The nationwide cohort estimated a 2.50% lifetime risk, with risk 50% higher in men than women.The nationwide cohort estimated a 2.50% lifetime risk, with risk 50% higher in men than women.

Cohort studyPopulations